Official UK procurement notice
European Viper Antivenom (2024)
Authority: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency (Central government)·Consortium: 2 public authorities
What is being bought
Published requirement descriptionContract for the supply of European Viper Antivenom
CPV: Pharmaceutical products
The lotProcurement structure
single lot · no lot value publishedLot #1Provision of European Viper AntivenomAwarded
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (4)
- Comparison with Specification: 30%
- Risk to programme delivery: 20%
- European Viper Antivenom price: 40%
- Social value: 10%
Published award criteria (4)
- Comparison with Specification: 30
- Risk to programme delivery: 20
- Social value: 10
- European Viper Antivenom price: 40
- Price carries 40 of 100 points: a 10% discount moves about 4 points. The method statement decides this lot, not the discount.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 28 Mar 2023, 11:50 BST
- Last source update
- 22 Apr 2026, 17:00 BST
- Award evaluation window
- 3 May 2023 – …
- FTS notice number
2026/S 000-036825- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-03b697Find a Tender
Publisher note: The contract is for the benefit of the contracting authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments and their executive agencies or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.
How it was run
Official noticeTender documents are also served through a separate tool: https://health-family.force.com/s/Welcome ↗
- Submission deadline
- 3 May 2023, 13:00 BST
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Bid validity
- 180 days from the deadline
- Bids opened
- 3 May 2023, 13:00 BST
Timeline
3 May 2023 → 22 Apr 2026 · 4 dates- Submission deadline3 May 2023, 13:00 BST
- Bids opened3 May 2023, 13:00 BST
- Contract starts1 May 2024, 00:00 BST
- Notice published187 days ago22 Apr 2026, 17:00 BST
Notice history
2 events · 4 releases on Find a Tender · since 27 Nov 2023- Status changed to complete27 Nov 2023, 13:50 GMT
- Buyer details updated27 Nov 2023, 13:50 GMT
Routine re-releases (4)
- 2023-03: 1 release · 28 Mar 2023
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Flynn Pharma Ltd | £1 †same award published again · counted once | — | Awarded |
| Flynn Pharma Ltd | £1 †same award published again · counted once | — | Awarded |
| Flynn Pharma Ltd | £1 † | — | Awarded |
Contracts
Contract 034944-2023-1 · Flynn Pharma Ltd
- Signed
- 8 Nov 2023
- Value
- £1
- Period
- … – 30 Apr 2026
- Status
- active
Contract 036823-2026-C228810-1 · Flynn Pharma Ltd
- Signed
- 8 Nov 2023
- Value
- £1
- Period
- 1 May 2024 – 30 Apr 2027
- Status
- active
- Change The Authority is invoking the flexibility provision contained within the contract for the initial term and is extending the contract by 12 months., Need for additional works, services or supplies by the original contractor/concessionaire: The Authority is invoking the contractual flexibility provision and the 12‑month extension to authorise an increase in the product volume.
Contract 036825-2026-C228810-1 · Flynn Pharma Ltd
- Signed
- 8 Nov 2023
- Value
- £1
- Period
- 1 May 2024 – 30 Apr 2027
- Status
- active
- Change The Authority is invoking the flexibility provision contained within the contract for the initial term and is extending the contract by 12 months., Need for additional works, services or supplies by the original contractor/concessionaire: The Authority is invoking the contractual flexibility provision and the 12‑month extension to authorise an increase in the product volume.
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
2 public bodies on the noticeDispute resolution & review bodies
- The High CourtReview body
Bidders & participating suppliers
1 commercial party on the notice- FLYNN PHARMA LTDAwarded supplier
Official documents & specifications (2)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria
- Technical selection criteria